NRG
39
4
SJM
21
2
MCK
59
3
FTI
63
2
ADT
27
2
CHRW
54
3
VNO
49
2
JBHT
48
2
VRSK
59
5
ZBH
71
3
CRM
67
2
ADI
59
2
AON
30
2
DTE
54
5
M
48
2
TSCO
48
5
EQT
48
6
IFF
47
3
DAL
64
3
APH
58
5
NRG
39
4
SJM
21
2
MCK
59
3
FTI
63
2
ADT
27
2
CHRW
54
3
VNO
49
2
JBHT
48
2
VRSK
59
5
ZBH
71
3
CRM
67
2
ADI
59
2
AON
30
2
DTE
54
5
M
48
2
TSCO
48
5
EQT
48
6
IFF
47
3
DAL
64
3
APH
58
5
Financhill
Back

Autolus Therapeutics PLC 10K Form

Sell
42

AUTL
Autolus Therapeutics PLC

Last Price:
$2.25
Seasonality Move:
-14.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive AUTL News And Ratings

See the #1 stock for the next 7 days that we like better than AUTL

AUTL Financial Statistics

Sales & Book Value

Annual Sales: $1.7M
Cash Flow: $-86.3M
Price / Cash Flow: 0
Annual Sales: $1.79
Price / Book: 1.26

Profitability

EPS (TTM): -1.22000
Net Income (TTM): $-270.2M
Gross Margin: --
Return on Equity: -80.74%
Return on Assets: -42.65%

Autolus Therapeutics PLC Earnings Forecast

Key Autolus Therapeutics PLC Financial Ratios

  • The Research & Development expenses have been 7,684.39% of Revenue.
  • The Interest Expense is -21.63% of Operating Income.
  • The Net Earning history of AUTL is -12,272.26% of Total Revenues.
  • Per Share Earnings over the last 8 years have been positive in 5 years.

Autolus Therapeutics PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: AUTL
CUSIP: 05280R
Website: autolus.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 18.29
Quick Ratio: 17.97

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

AUTL Technical Analysis vs Fundamental Analysis

Sell
42
Autolus Therapeutics PLC (AUTL) is a Sell

Is Autolus Therapeutics PLC a Buy or a Sell?